AXL1717

AXL1717 · Axelar AB

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AXL1717, covering 2011-09-15 to 2023-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas [Phase 1, Phase 2]